By John Jones, Founder and CEO of Entitech Solutions
I’m thrilled to announce that Entitech Solutions has been acquired by Tandym Group, marking what I believe will be a defining moment in a journey to reshape the healthcare and life sciences technology landscape. For Entitech, this represents not just an acquisition, but a strategic alignment that will amplify our ability to provide value in ways we’ve only dreamed of until now.
What excites me most about partnering with Tandym Group is their established reputation as a high-volume staffing provider with an extensive pool of recruiting talent. Throughout my tenure leading Entitech, I’ve witnessed firsthand how talent acquisition constraints can limit even the most specialized firms. Tandym’s track record of successful acquisitions—including Longford & Company, Kolter Solutions, AETEA Information Technology, and Metro Systems Inc.—demonstrates their ability to integrate and scale specialized technology firms like ours.
Tandym’s deep recruiting infrastructure positions us for unprecedented growth together. With access to Tandym’s vast network of technology professionals and their proven scaling methodologies, we can now expand our operations to meet the growing demand for healthcare and life sciences technology.
I’m proud to have led Entitech as we’ve established ourselves as a premier provider of innovative technology services addressing the unique needs of the healthcare and life sciences industries. What has always set us apart is our ability to deliver enterprise-level solution implementation capabilities that rival major management consulting firms like Accenture and Deloitte, but with a significantly higher success rate due to our specialized focus and deep industry expertise.
I’ve watched our team develop tailored solutions that help healthcare and life sciences companies excel at their core work, including our Connection as a Service™ (CaaS™) platform that provides a holistic approach to data integration. One area where I’ve seen our CaaS™ platform make a particularly significant impact is in enabling seamless data flow between Clinical Trial Management Systems (CTMS) and Electronic Data Capture (EDC) systems—solving one of the most persistent challenges in the typical clinical trial operations heterogeneous IT ecosystem.
Our expertise in clinical trial data integration has proven particularly valuable in today’s complex regulatory environment. I’ve had the privilege of working with Top 5 pharmaceutical companies to implement regulatory data hubs and flexible integration architectures that have even enabled connecting directly to site Electronic Medical Record (EMR) systems.
This specialized knowledge, combined with proven results like reducing cycle time and boosting productivity for both our drug manufacturer and contract research organization (CRO) clients, makes me confident that we bring invaluable expertise to healthcare and life sciences companies seeking to optimize their technology infrastructure.
Tandym Group’s commitment to technological advancement aligns perfectly with where I see the healthcare and life sciences sectors heading. I’m particularly excited about the recent addition of AI Agents to Tandym Catalyst™. This AI-enabled approach represents a significant competitive advantage in our industry, where data accuracy, speed, and scalability are paramount.
I envision tremendous opportunities in integrating Tandym’s AI capabilities with our domain expertise to create innovative solutions that address complex challenges in clinical trial management, regulatory compliance, and data integration.
This acquisition represents more than just a business combination for me—it’s a strategic alignment that positions us to better serve the evolving needs of the healthcare and life sciences industry. Our mission at Entitech has always been to help companies meet process optimization goals at a fraction of the cost by simplifying technology and making existing systems work better. This perfectly complements Tandym’s scalable talent solutions and AI-driven approach.
Entitech as part of Tandym is uniquely positioned to address the growing demand for specialized healthcare and life sciences technology solutions while maintaining the agility and innovation that our clients expect. As the healthcare and life sciences industries continue to embrace digital transformation, this partnership provides the foundation for delivering next-generation solutions that drive operational efficiency and accelerate breakthrough discoveries.
The acquisition of Entitech Solutions by Tandym Group signals a new chapter in healthcare and life sciences technology services—one where deep domain expertise, scalable talent solutions, and cutting-edge AI capabilities converge to create unprecedented value for clients navigating the complex landscape of modern operations.
I’m incredibly excited about what lies ahead for our team, our clients, and the future of healthcare and life sciences technology innovation!